The emerging role of fumarate as an oncometabolite.
The drive to understand how altered cellular metabolism and cancer are linked has caused a paradigm shift in the focus of cancer research. The discovery of a mutated metabolic enzyme, isocitrate dehydrogenase 1, that leads to accumulation of the oncometabolite 2-hydroxyglutarate, provided significan...
| Autors principals: | , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
2012
|
| _version_ | 1826291525437358080 |
|---|---|
| author | Yang, M Soga, T Pollard, P Adam, J |
| author_facet | Yang, M Soga, T Pollard, P Adam, J |
| author_sort | Yang, M |
| collection | OXFORD |
| description | The drive to understand how altered cellular metabolism and cancer are linked has caused a paradigm shift in the focus of cancer research. The discovery of a mutated metabolic enzyme, isocitrate dehydrogenase 1, that leads to accumulation of the oncometabolite 2-hydroxyglutarate, provided significant direct evidence that dysfunctional metabolism plays an important role in oncogenesis. Striking parallels exist with the Krebs cycle enzyme fumarate hydratase (FH), a tumor suppressor, whose mutation is associated with the development of leiomyomata, renal cysts, and tumors. Loss of FH enzymatic activity results in accumulation of intracellular fumarate which has been proposed to act as a competitive inhibitor of 2-oxoglutarate-dependent oxygenases including the hypoxia-inducible factor (HIF) hydroxylases, thus activating oncogenic HIF pathways. Interestingly, our studies have questioned the role of HIF and have highlighted other candidate mechanisms, in particular the non-enzymatic modification of cysteine residues (succination) that could lead to disruption or loss of protein functions, dysfunctional cell metabolism and cell signaling. Here, we discuss the evidence for proposing fumarate as an onco-metabolite. |
| first_indexed | 2024-03-07T03:00:42Z |
| format | Journal article |
| id | oxford-uuid:b0df2555-7224-4a10-bae3-95dee0491f4d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:00:42Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:b0df2555-7224-4a10-bae3-95dee0491f4d2022-03-27T03:59:33ZThe emerging role of fumarate as an oncometabolite.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b0df2555-7224-4a10-bae3-95dee0491f4dEnglishSymplectic Elements at Oxford2012Yang, MSoga, TPollard, PAdam, JThe drive to understand how altered cellular metabolism and cancer are linked has caused a paradigm shift in the focus of cancer research. The discovery of a mutated metabolic enzyme, isocitrate dehydrogenase 1, that leads to accumulation of the oncometabolite 2-hydroxyglutarate, provided significant direct evidence that dysfunctional metabolism plays an important role in oncogenesis. Striking parallels exist with the Krebs cycle enzyme fumarate hydratase (FH), a tumor suppressor, whose mutation is associated with the development of leiomyomata, renal cysts, and tumors. Loss of FH enzymatic activity results in accumulation of intracellular fumarate which has been proposed to act as a competitive inhibitor of 2-oxoglutarate-dependent oxygenases including the hypoxia-inducible factor (HIF) hydroxylases, thus activating oncogenic HIF pathways. Interestingly, our studies have questioned the role of HIF and have highlighted other candidate mechanisms, in particular the non-enzymatic modification of cysteine residues (succination) that could lead to disruption or loss of protein functions, dysfunctional cell metabolism and cell signaling. Here, we discuss the evidence for proposing fumarate as an onco-metabolite. |
| spellingShingle | Yang, M Soga, T Pollard, P Adam, J The emerging role of fumarate as an oncometabolite. |
| title | The emerging role of fumarate as an oncometabolite. |
| title_full | The emerging role of fumarate as an oncometabolite. |
| title_fullStr | The emerging role of fumarate as an oncometabolite. |
| title_full_unstemmed | The emerging role of fumarate as an oncometabolite. |
| title_short | The emerging role of fumarate as an oncometabolite. |
| title_sort | emerging role of fumarate as an oncometabolite |
| work_keys_str_mv | AT yangm theemergingroleoffumarateasanoncometabolite AT sogat theemergingroleoffumarateasanoncometabolite AT pollardp theemergingroleoffumarateasanoncometabolite AT adamj theemergingroleoffumarateasanoncometabolite AT yangm emergingroleoffumarateasanoncometabolite AT sogat emergingroleoffumarateasanoncometabolite AT pollardp emergingroleoffumarateasanoncometabolite AT adamj emergingroleoffumarateasanoncometabolite |